Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 03, 2015 10:37 PM ET

Biotechnology

Company Overview of Achillion Pharmaceuticals, Inc.

Executive Profile

Jules L. Dienstag M.D.

Former Member of Clinical Advisory Board, Achillion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
----

Background

Dr. Jules L. Dienstag, M.D. serves as Carl W. Walter Professor of Medicine and Physician, Gastrointestinal Unit of Harvard Medical School and Massachusetts General Hospital , Boston, Massachusetts of Harvard University. Dr. Dienstag is a Physician at Massachusetts General Hospital. He is recognized worldwide as a leader in pre-clinical and clinic hepatitis research. He is one of the Principle Investigators of the NIH-NIDDK-supported Hepatitis C Antiviral Long-term Treatment ...

Corporate Headquarters

300 George Street
New Haven, Connecticut 06511

United States

Phone: 203-624-7000
Fax: 203-624-7003

Board Members Memberships

Member of Board of Trustees

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
$3.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.1M
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Achillion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.